| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Nov 17, 2023 19:50 |
| Status | New |
| Announcement Sub Title | Appointment of Non-Executive Director |
| Announcement Reference | SG231117OTHRD5MU |
| Submitted By (Co./ Ind. Name) | Yong Yean Chau |
| Designation | Director / Chief Executive Officer |
| Description (Please provide a detailed description of the event in the box below) | Appointment of Non-Executive Director |
| Additional Details | |
| Date Of Appointment | 17/11/2023 |
| Name Of Person | Tomo Nagahiro |
| Age | 47 |
| Country Of Principal Residence | Japan |
| The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) | Mr. Tomo Nagahiro was nominated by Parkway Holdings Limited, the holding company of Parkway Trust Management Limited (Company). The Nominating and Remuneration Committee of the Company (NRC) has reviewed the qualification and experience of Mr. Tomo Nagahiro and recommended to the Board the appointment of Mr. Tomo Nagahiro as a Non-Executive Director of the Company. The Board considered the recommendation of NRC and approved his appointment. |
| Whether appointment is executive, and if so, the area of responsibility | Non-executive |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Executive Director |
| Professional qualifications | - Bachelor of Arts in Law (concentration in Administration Law), The University of Tokyo, Japan - U.S. Certified Public Accountant - State of Delaware, U.S.A - Master of Business Administration, Kellogg School of Management, Northwestern University, U.S.A. |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries | Mr. Tomo Nagahiro is a Non-Independent and Non Executive Director of IHH Healthcare Berhad and a Non Executive Director of MBK Healthcare Management Pte. Ltd., both of which are substantial shareholders of Parkway Life REIT |
| Conflict of interests (including any competing business) | Nil, except for the directorship held by Mr. Tomo Nagahiro in Fortis Healthcare Limited, IHH Healthcare Berhad and MBK Healthcare Management Pte. Ltd. |
| Working experience and occupation(s) during the past 10 years | - 2023 to Present - General Manager of Healthcare Services & Data Business Department (Wellness Business Unit), Mitsui & Co., Ltd - 2019 to 2023 - General Manager of Strategic Planning Department (Wellness Business Unit), Mitsui & Co., Ltd - 2019 to 2021 - General Manager of Healthcare Business 1st Department (Healthcare Business Division), Mitsui & Co., Ltd - 2015 to 2018 - Chief Operating Officer of MIMS Pte. Ltd. - 2013 to 2015 - Assistant Vice President of Strategic Planning and Business Development, Parkway Group Healthcare Pte. Ltd. - 2012 to 2013 - Manager of Business Development,Medical Healthcare Business Division 1, Mitsui & Co., Ltd |
| Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) | Yes |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | Please refer to Annexure A attached |
| Present | Please refer to Annexure B attached |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of an issuer listed on the Exchange? | Yes |
| If Yes, Please provide details of prior experience | Non-Independent and Non-Executive Director of IHH Healthcare Berhad |
Attachments
The information behind this electronic gatepost is only being made available to residents of Singapore.
In particular, the units of Parkway Life Real Estate Investment Trust have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the U.S. Securities Act.
The units of Parkway Life Real Estate Investment Trust are only being offered outside the United States in reliance on Regulation S under the U.S. Securities Act or otherwise pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the U.S.
By clicking on the "I agree" button below, you will have acknowledged the foregoing restrictions and represented that you are resident in Singapore and are not accessing this website from jurisdictions outside of Singapore, including the United States.